Novalis LifeSciences Launches its Second Life Science Investment Fund with $300M and announces key new team members.
Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry, announced today that is has raised $300M in capital for its second fund – Novalis LifeSciences Investments II...
December 9, 2021
by prnasia
American Humane's Feed the Hungry COVID-19 Fund Provides One Million Meals
American Humane, the country's first national humane organization, today announced that its Feed the Hungry COVID-19 fund provided one million meals to hungry animals in need.
June 30, 2021
by prnewswire
Stelis concludes $195 million Series B and Series C fund raise
Stelis Biopharma (Stelis) announced that it has successfully concluded its Series B and Series C fund raise for a cumulative amount of $195 million.
March 19, 2021
by expresspharma
Colorcon Ventures Invests in i20 Therapeutics
i2O Therapeutics, a biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc.
December 8, 2020
by contractpharma
Gov unveils fund for follow-on care
The government has announced a fund of £588 million for people needing follow-on care after being discharged from hospital.
August 24, 2020
by pharmatimes
Epidarex Capital closes life sciences venture fund at £102m
Epidarex Capital has closed a new fund destined to help build successful new life sciences companies in the UK at £102 million.
June 24, 2020
by pharmatimes
Colorcon Launches $50M Venture Capital Fund
Colorcon, a provider of development, supply and technical support of specialty products for the pharmaceutical industry, has established Colorcon Ventures to invest in promising companies in the pharmaceutical industry.
September 19, 2019
by contractpharma
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people
Gavi, the Vaccine Alliance has initiated a $7.4bn fundraising drive to support the immunisation of 300 million children against 18 diseases, which could save up to eight million lives from 2021-25.
September 3, 2019
by pharmaceutical-technology
Global Fund seeks $14bn to fight AIDS, TB and malaria
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to tackle these serious public health concerns.
January 15, 2019
by pharmaceutical-technology
Wellcome Trust announces £250m fund for high risk ideas
The London-based biomedical research charity the Wellcome Trust, Britain’s wealthiest foundation, has announced the launch of a new £250 million fund that will place “big bets” on ambitious research programmes aimed at fundamentally transforming science a
July 17, 2018
by pharmafile
Pfizer's Xalkori makes it onto Cancer Drugs Fund
NICE has published draft guidance recommending that Pfizer's Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung cancer is made available via the Cancer Drugs Fund (CDF).
July 11, 2018
by pharmatimes
Pivotal bioVenture Partners debuts $150M China-focused biotech fund
The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China.
May 28, 2018
by fiercebiotech